Fibroblast Diversity and Epigenetic Regulation in Cardiac Fibrosis

Laura Pilar Aguado-Alvaro,Nerea Garitano,Beatriz Pelacho
DOI: https://doi.org/10.3390/ijms25116004
IF: 5.6
2024-05-31
International Journal of Molecular Sciences
Abstract:Cardiac fibrosis, a process characterized by excessive extracellular matrix (ECM) deposition, is a common pathological consequence of many cardiovascular diseases (CVDs) normally resulting in organ failure and death. Cardiac fibroblasts (CFs) play an essential role in deleterious cardiac remodeling and dysfunction. In response to injury, quiescent CFs become activated and adopt a collagen-secreting phenotype highly contributing to cardiac fibrosis. In recent years, studies have been focused on the exploration of molecular and cellular mechanisms implicated in the activation process of CFs, which allow the development of novel therapeutic approaches for the treatment of cardiac fibrosis. Transcriptomic analyses using single-cell RNA sequencing (RNA-seq) have helped to elucidate the high cellular diversity and complex intercellular communication networks that CFs establish in the mammalian heart. Furthermore, a significant body of work supports the critical role of epigenetic regulation on the expression of genes involved in the pathogenesis of cardiac fibrosis. The study of epigenetic mechanisms, including DNA methylation, histone modification, and chromatin remodeling, has provided more insights into CF activation and fibrotic processes. Targeting epigenetic regulators, especially DNA methyltransferases (DNMT), histone acetylases (HAT), or histone deacetylases (HDAC), has emerged as a promising approach for the development of novel anti-fibrotic therapies. This review focuses on recent transcriptomic advances regarding CF diversity and molecular and epigenetic mechanisms that modulate the activation process of CFs and their possible clinical applications for the treatment of cardiac fibrosis.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The paper primarily explores the diversity of cardiac fibroblasts (CFs) and their epigenetic regulatory mechanisms in cardiac fibrosis, and attempts to address the following key issues: 1. **Diversity of Cardiac Fibroblasts**: - The study utilizes single-cell transcriptomics technology to reveal different subpopulations of cardiac fibroblasts and their dynamic changes in healthy and diseased states. - The paper describes the molecular characteristics of different cardiac fibroblast subpopulations, including their activation, proliferation, and differentiation into myofibroblasts after cardiac injury. 2. **Epigenetic Regulatory Mechanisms**: - It explores the roles of epigenetic mechanisms such as DNA methylation, histone modifications, and chromatin remodeling in the activation process of cardiac fibroblasts. - Special attention is given to the functions of epigenetic regulatory factors like DNA methyltransferases (DNMTs), histone acetyltransferases (HATs), and histone deacetylases (HDACs) in cardiac fibrosis. 3. **Potential Therapeutic Strategies**: - The paper proposes the possibility of targeting specific epigenetic regulatory factors (such as DNMTs, HATs, and HDACs) as novel anti-fibrotic therapies. - It emphasizes the development of new therapeutic approaches by targeting these epigenetic mechanisms to reverse the pathological process of cardiac fibrosis. In summary, the paper aims to provide new insights and methods for the treatment of cardiac fibrosis through a deep understanding of the diversity of cardiac fibroblasts and their epigenetic regulatory mechanisms.